{
    "clinical_study": {
        "@rank": "68756", 
        "arm_group": [
            {
                "arm_group_label": "morphine, epidural", 
                "arm_group_type": "Active Comparator", 
                "description": "Epidurally administrated morphine"
            }, 
            {
                "arm_group_label": "fentanyl, epidural", 
                "arm_group_type": "Active Comparator", 
                "description": "epidurally administrated fentanyl"
            }, 
            {
                "arm_group_label": "methadone, epidural", 
                "arm_group_type": "Active Comparator", 
                "description": "epidurally administrated methadone"
            }, 
            {
                "arm_group_label": "morphine, intervenous", 
                "arm_group_type": "Active Comparator", 
                "description": "intravenously administrated morphine"
            }
        ], 
        "brief_summary": {
            "textblock": "The current study aim is to compare between the opioids morphine, fentanyl and methadone in\n      terms of efficacy and side effects profile when administered epidurally for pain management\n      after laparotomies. Intravenous morphine will also be used. The outcomes of that method will\n      be compared to those obtained using epidurally administered opioids, as this is another\n      commonly used postoperative pain relief method."
        }, 
        "brief_title": "A Prospective Comparison of Methadone, Fentanyl, and Morphine for Post-laparotomy Epidural Analgesia", 
        "condition": "Post Laparotomy Pain Treatment", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        * Elective laparotomy\n\n        Exclusion Criteria:\n\n          -  Subjects with diabetes mellitus, other neurological or systemic disease associated\n             with altered sensory perception\n\n          -  Illicit drug abusers\n\n          -  Chronic use of pain medication\n\n          -  Inability to understand consent form\n\n          -  Age < 18\n\n          -  Renal failure (Clcr<50 ml/min)\n\n          -  Chronic use of drugs that can alter  plasma levels and\\or effect of the study drugs\n\n          -  Corrected Q-T interval(QTc)=450msc and above\n\n          -  Contra-indication for epidural catheter insertion\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01828840", 
            "org_study_id": "0080-10-HMO"
        }, 
        "intervention": [
            {
                "arm_group_label": "morphine, epidural", 
                "intervention_name": "epidural morphine via PCEA", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "fentanyl, epidural", 
                "intervention_name": "epidural fentanyl via PCEA", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "methadone, epidural", 
                "intervention_name": "epidural methadone via PCEA", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "morphine, intervenous", 
                "intervention_name": "intravenous morphine via PCA", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fentanyl", 
                "Methadone", 
                "Morphine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "morphine", 
            "fentanyl", 
            "methadone", 
            "epidural", 
            "intravenous", 
            "pain", 
            "analgesia"
        ], 
        "lastchanged_date": "April 8, 2013", 
        "location": {
            "contact": {
                "email": "lhadas@hadassah.org.il", 
                "last_name": "Hadas Lemberg, Phd", 
                "phone": "972507874098"
            }, 
            "contact_backup": {
                "email": "Edavidson@hadassah.org.il", 
                "last_name": "Elyad Davidson, MD", 
                "phone": "972507874098"
            }, 
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel", 
                    "zip": "91120"
                }, 
                "name": "Hadassah Medical Organization"
            }, 
            "investigator": {
                "last_name": "Elyad Davidson, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Prospective Double Blind Randomized Comparison of Methadone, Fentanyl, and Morphine for Post-laparotomy Epidural Analgesia.", 
        "overall_contact": {
            "email": "lhadas@hadassah.org.il", 
            "last_name": "Hadas Lemberg, Phd", 
            "phone": "0097226777572"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Variable stimuli, fixed response: measurement of pain tolerance by gradual increase of temperature (quantitative sensory testing (QST))as compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "72 hours post operatively"
            }, 
            {
                "measure": "Fixed stimuli, variable response: measurement of reaction to fixed temperature by visual analog scale (VAS) as well as Variable stimuli, variable response (electrical stimuli)as compared to baseline.", 
                "safety_issue": "No", 
                "time_frame": "72 hours post operatively"
            }, 
            {
                "measure": "patient controlled epidural analgesia (PCEI)/patient controlled analgesia (PCA)dose frequency as compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "72 hours post operatively"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01828840"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Measurement of  opioid concentration in plasma as compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 hours post surgery and twice daily for 72 hours starting 18-24 hours post surgery"
            }, 
            {
                "measure": "Pupillometry as compared to baseline", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and twice daily for 72 hours starting 18-24 hours post surgery"
            }, 
            {
                "measure": "Respiratory rate as compared to baseline", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, 4 hours post surgery and twice daily for 72 hours starting 18-24 hours post surgery"
            }, 
            {
                "measure": "Nasal capnography at rest as compared to baseline", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and twice daily for 72 hours starting 18-24 hours post surgery"
            }, 
            {
                "measure": "Report of adverse effects' severity as compared to baseline", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, 4 hours post surgery and twice daily for 72 hours starting 18-24 hours post surgery"
            }, 
            {
                "measure": "Report of pain severity- at rest, cough and deep breathing as compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 hours post surgery and twice daily for 72 hours starting 18-24 hours post surgery"
            }
        ], 
        "source": "Hadassah Medical Organization", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hadassah Medical Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}